Canada Chemiluminescence Immunoassay Market Size & Outlook
Related Markets
Canada chemiluminescence immunoassay market highlights
- The Canada chemiluminescence immunoassay market generated a revenue of USD 309.1 million in 2020 and is expected to reach USD 589.2 million by 2028.
- The Canada market is expected to grow at a CAGR of 8.4% from 2021 to 2028.
- In terms of segment, consumables was the largest revenue generating product & services in 2020.
- Consumables is the most lucrative product & services segment registering the fastest growth during the forecast period.
Chemiluminescence immunoassay market data book summary
| Market revenue in 2020 | USD 309.1 million |
| Market revenue in 2028 | USD 589.2 million |
| Growth rate | 8.4% (CAGR from 2020 to 2028) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments, Software & Services |
| Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
Other key industry trends
- In terms of revenue, Canada accounted for 4.2% of the global chemiluminescence immunoassay market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. chemiluminescence immunoassay market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 589.2 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Chemiluminescence Immunoassay Market Scope
Chemiluminescence Immunoassay Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Maccura | View profile | 1001-5000 | Chengdu, Sichuan, China, Asia | http://www.maccura.com/en |
| Inova Diagnostics | View profile | 51-100 | San Diego, California, United States, North America | http://inovadx.com |
| Immunodiagnostic Systems | View profile | 251-500 | Boldon, Durham, United Kingdom, Europe | http://www.idsplc.com |
| shenzhen mindray automation equipment co. | View profile | 101-250 | Baoan, Guangdong, China, Asia | https://www.mindray-ele.com |
| Beckman Coulter | View profile | 10001+ | Brea, California, United States, North America | http://www.beckmancoulter.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Diasorin SpA | View profile | 3233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | https://www.diasoringroup.com |
| QuidelOrtho Corp | View profile | 7100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | https://www.quidelortho.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Canada chemiluminescence immunoassay market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.32% in 2020. Horizon Databook has segmented the Canada chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Increasing initiatives being undertaken by local players and growing market penetration of key players in Canada to fulfill the growing demand for CLIA products are among major factors propelling the market growth.
In May 2020, DiaSorin received Health Canada’s approval for its new LIAISON SARS-CoV-2 S1/S2 IgG test for the detection of Covid-19 in Canada. Furthermore, rising prevalence of chronic & infectious diseases and increasing healthcare expenditure in Canada are among factors anticipated to boost the market growth over the forecast period.
For instance, according to NCBI, in 2018, around 2,561 people in Canada were diagnosed with HIV, accounting for an increase of 8.2% from the previous year. Moreover, rise in the number of awareness programs is likely to drive the market.
Reasons to subscribe to Canada chemiluminescence immunoassay market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada chemiluminescence immunoassay market databook
-
Our clientele includes a mix of chemiluminescence immunoassay market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into Canada chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Canada chemiluminescence immunoassay market size, by product & services, 2016-2028 (US$M)
Canada Chemiluminescence Immunoassay Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
